Herc Holdings' Dip Offers An Entry Point
Herc Holdings' Dip Offers An Entry Point
Similar Posts
A bright future for biotech – what to buy
Good news for shareholders in the International Biotechnology Trust: their fund has a significant holding in US cancer research business Nuvalent, for which GSK has just agreed to pay $10.6 billion– 40% more than its share price prior to the deal being announced. Even better: Nuvalent is the sixth company in the portfolio to have…
Can you beat the market? Maybe with this strategy.
This could be the right time to buy a momentum fund
SRAD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Sportradar (SRAD) Investors of Securities Class Action Lawsuit Deadline on July 17, 2026
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making…
Debt funds or direct bonds? Understanding the routes to fixed income investing
Sebi’s reforms and online bond platforms have made direct bond investing more accessible than ever. But should investors choose individual bonds over debt mutual funds—or use both?
